Search Images Maps Play YouTube News Gmail Drive More »
Advanced Patent Search | Web History | Sign in

Patents

Referenced by

Citing PatentFiling dateIssue dateOriginal AssigneeTitle
US39956354 Nov 19747 Dec 1976Alza CorporationOcular insert
US413617331 Jan 197723 Jan 1979American Home Products Corp.Mixed xanthan gum and locust beam gum therapeutic compositions
US413617731 Jan 197723 Jan 1979American Home Products Corp.Xanthan gum therapeutic compositions
US413617831 Jan 197723 Jan 1979American Home Products Corp.Locust bean gum therapeutic compositions
US420121028 Nov 19776 May 1980The United States of America as represented by the Secretary of AgricultureVeterinary ocular ring device for sustained drug release
US43042263 Mar 19808 Dec 1981The Procter & Gamble CompanyVaginal contraceptive
US495921722 May 198625 Sep 1990Syntex (U.S.A.) Inc.Delayed/sustained release of macromolecules
US527005115 Oct 199114 Dec 1993Enzyme-orthokeratology
US537847521 Feb 19913 Jan 1995University of Kentucky Research FoundationSustained release drug delivery devices
US547243626 Jul 19945 Dec 1995Ocular appliance for delivering medication
US562686518 Jul 19946 May 1997Advanced Corneal Systems, Inc.Enzyme-orthokeratology
US577301927 Sep 199530 Jun 1998The University of Kentucky Research FoundationImplantable controlled release device to deliver drugs directly to an internal portion of the body
US578895712 Sep 19964 Aug 1998Advanced Corneal Systems, Inc.Enzyme-orthokeratology
US58764383 May 19962 Mar 1999Houston Biotechnology IncorporatedPolymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US590259828 Aug 199711 May 1999Control Delivery Systems, Inc.Sustained release drug delivery devices
US606311627 Jun 199716 May 2000Medarex, Inc.Modulation of cell proliferation and wound healing
US613273518 Sep 199717 Oct 2000ISTA Pharmaceutical, Inc.Enzyme-orthokeratology
US616154428 Jan 199819 Dec 2000Keratoform, Inc.Methods for accelerated orthokeratology
US62649714 Nov 199924 Jul 2001BTG International LimitedOcular insert
US63031027 Sep 200016 Oct 2001Cutaneously applied biodegradable tell-tale having controllable clearing time
US633131322 Oct 199918 Dec 2001Oculex Pharmaceticals, Inc.Controlled-release biocompatible ocular drug delivery implant devices and methods
US637597226 Apr 200023 Apr 2002Control Delivery Systems, Inc.Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US64132454 Oct 20002 Jul 2002Alcon Universal Ltd.Sub-tenon drug delivery
US641354012 Sep 20002 Jul 2002Alcon Universal Ltd.Drug delivery device
US641677719 Sep 20009 Jul 2002Alcon Universal Ltd.Ophthalmic drug delivery device
US66699501 Jul 200230 Dec 2003Alcon, Inc.Ophthalmic drug delivery device
US669949328 Nov 20012 Mar 2004Oculex Pharmaceuticals, Inc.Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US675604917 Dec 200129 Jun 2004Bausch & Lomb IncorporatedSustained release drug delivery devices
US675605827 Dec 200129 Jun 2004Bausch & Lomb IncorporatedSustained release drug delivery devices with multiple agents
US68087191 Jul 200226 Oct 2004Alcon, Inc.Drug delivery device
US696478127 Dec 200115 Nov 2005Bausch & Lomb IncorporatedSustained release drug delivery devices with prefabricated permeable plugs
US69869005 Nov 200317 Jan 2006Alcon, Inc.Ophthalmic drug delivery device
US699180823 Jan 200231 Jan 2006Bausch & Lomb Inc.Process for the production of sustained release drug delivery devices
US703360522 Dec 200325 Apr 2006Allergan, Inc.Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US709422612 Nov 200322 Aug 2006Alcon, Inc.Ophthalmic drug delivery device
US718128724 Jul 200220 Feb 2007Second Sight Medical Products, Inc.Implantable drug delivery device
US752762116 Aug 20065 May 2009Second Sight Medical Products, Inc.Implantable drug delivery device
US75632552 May 200221 Jul 2009Massachusetts Eye and Ear Infirmary
The Charles Stark Draper Laboratory Inc.
Implantable drug delivery device and use thereof
US758551720 Sep 20048 Sep 2009Macusight, Inc.Transscleral delivery
US762190711 Mar 200324 Nov 2009Alcon, Inc.Implantable drug delivery system
US762558220 Apr 20071 Dec 2009Allergan, Inc.Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US770871112 Nov 20034 May 2010Glaukos CorporationOcular implant with therapeutic agents and methods thereof
US776722311 Jul 20053 Aug 2010Allergan, Inc.Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
US782470415 Aug 20052 Nov 2010Surmodics, Inc.Controlled release bioactive agent delivery device
US78464683 Nov 20087 Dec 2010Allergan, Inc.Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US79431627 Dec 200617 May 2011Alcon, Inc.Drug delivery device
US797686215 Aug 200512 Jul 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US802168029 Apr 200420 Sep 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US803436631 Oct 200711 Oct 2011Allergan, Inc.Ocular implant made by a double extrusion process
US803436912 Sep 200511 Oct 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US803437031 Oct 200711 Oct 2011Allergan, Inc.Ocular implant made by a double extrusion process
US804362831 Oct 200725 Oct 2011Allergan, Inc.Methods for reducing edema
US807112030 Mar 20066 Dec 2011Allergan, Inc.Methods for treating neovascularization and intravitreal implants
US80884077 Sep 20073 Jan 2012Allergan, Inc.Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
US809697219 Dec 200317 Jan 2012Johns Hopkins UniversityDevices for intraocular drug delivery
US816785525 Aug 20041 May 2012Vista Scientific LLCOcular drug delivery device
US817774730 Nov 201015 May 2012Alcon Research, Ltd.Method and apparatus for drug delivery
US822227123 Mar 200717 Jul 2012Santen Pharmaceutical Co., Ltd.Formulations and methods for vascular permeability-related diseases or conditions
US824209912 Oct 201114 Aug 2012Allergan, Inc.Implants and methods for treating inflammation-mediated conditions of the eye